Is Alnylam Pharmaceuticals, Inc. overvalued?

Alnylam Pharmaceuticals, Inc. (ALNY) — key valuation metrics and fundamentals.

No verdict

Price

$291.37

Fair value

—

Current P/E

—

Normal P/E

—

Market cap

$38.90B

Dividend yield

0.0%

Return on equity

39.8%

Sector

Healthcare

Fair value compares ALNY's current P/E to its own historical "normal" P/E (FAST Graphs-style). Updated 28 Jun 2026.

Related stocks